Rasalect 0.5 Tablet

Rasalect 0.5 Tablet contains Rasagiline (0.5mg) and is used for Parkinson’s disease, as monotherapy in early. Prescription required.

Treatment of Parkinson’s disease, as monotherapy in early Parkinson’s disease or as add-on to levodopa in patients with motor fluctuations (wearing-off).

Rasagiline is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor. It increases dopamine levels in the brain by reducing dopamine breakdown, improving motor symptoms of Parkinson’s disease.

Oral tablet; take exactly as prescribed, usually once daily at the same time each day. Can be taken with or without food. Do not stop or change dose without medical advice.

Headache,dizziness,insomnia,nausea,dyspepsia,abdominal pain,arthralgia,back pain,orthostatic hypotension,dry mouth

Prescription medicine. Risk of hypertensive crisis with tyramine-rich foods or interacting drugs; follow diet/medicine advice. May cause dizziness or orthostatic hypotension—use caution while driving/standing up. Watch for serotonin syndrome when combined with serotonergic medicines. Use caution in hepatic impairment; avoid in severe liver disease. Report hallucinations, impulse-control disorders, or worsening dyskinesia (especially with levodopa).

SSRIs/SNRIs/TCAs (serotonin syndrome risk),MAO inhibitors or linezolid/methylene blue (contraindicated),meperidine/tramadol/methadone (serious reactions),dextromethorphan (avoid),sympathomimetics/decongestants (hypertension risk),ciprofloxacin and other CYP1A2 inhibitors (increase rasagiline levels),levodopa (may increase dyskinesia)

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Azilect 0.5 Tablet,Rasagiline 0.5 mg Tablet (generic),Rasalect 1 Tablet,Azilect 1 Tablet,Rasagiline 1 mg Tablet (generic)